Accessibility Menu
 
Bioceres Crop Solutions logo

Bioceres Crop Solutions

(NASDAQ) BIOX

Current Price$0.54
Market Cap$34.16M
Since IPO (2019)-89%
5 Year-95%
1 Year-88%
1 Month+4%

Bioceres Crop Solutions Financials at a Glance

Market Cap

$34.16M

Revenue (TTM)

$285.11M

Net Income (TTM)

$235.97M

EPS (TTM)

$-0.99

P/E Ratio

-0.55

Dividend

$0.00

Beta (Volatility)

0.68 (Low)

Price

$0.54

Volume

20,444

Open

$0.49

Previous Close

$0.54

Daily Range

$0.49 - $0.57

52-Week Range

$0.35 - $5.18

BIOX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bioceres Crop Solutions

Industry

Chemicals

Sector

Materials

Employees

751

CEO

Federico Trucco, PhD

Headquarters

Rosario, 2000, AR

BIOX Financials

Key Financial Metrics (TTM)

Gross Margin

37%

Operating Margin

0%

Net Income Margin

-83%

Return on Equity

-34%

Return on Capital

0%

Return on Assets

-42%

Earnings Yield

-1.82%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$34.16M

Shares Outstanding

63.23M

Volume

20.44K

Short Interest

0.00%

Avg. Volume

931.55K

Financials (TTM)

Gross Profit

$130.20M

Operating Income

$3.70M

EBITDA

$13.59M

Operating Cash Flow

$49.91M

Capital Expenditure

$14.61M

Free Cash Flow

$35.30M

Cash & ST Invst.

$34.74M

Total Debt

$276.61M

Bioceres Crop Solutions Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$73.67M

-31.0%

Gross Profit

$26.31M

-41.7%

Gross Margin

35.71%

N/A

Market Cap

$34.16M

N/A

Market Cap/Employee

$85.41K

N/A

Employees

400

N/A

Net Income

$183.04M

-183139.8%

EBITDA

$6.84M

-42.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$226.88M

+10.8%

Accounts Receivable

$165.84M

-30.8%

Inventory

$67.15M

-36.8%

Long Term Debt

$42.27M

-73.8%

Short Term Debt

$197.18M

+58.4%

Return on Assets

-42.11%

N/A

Return on Invested Capital

0.29%

N/A

Free Cash Flow

$17.17M

+195.1%

Operating Cash Flow

$17.39M

+212.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LVROLavoro Limited
$0.13+0.00%
WWRWestwater Resources, Inc.
$0.63-3.91%
HLPHongli Group Inc.
$0.84-1.19%
FSIFlexible Solutions International, Inc.
$5.32-0.93%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About BIOX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.